Abstract Alveolar soft part sarcoma (ASPS) is an exceptionally rare non-rhabdomyosarcomatous soft tissue sarcoma (NRSTS), characterized by the translocation t(X;17) p(11.2;q25). This translocation results in the chimeric ASPSCR1-TFE3 transcription factor which drives tumorigenesis. Complete surgical resection is crucial in allowing a successful outcome in these cases. Here, we describe an 11-month-old female infant who presented with a well-circumscribed lesion of the tongue, with the clinical and radiologic appearances of an infantile hemangioma. This led to an initial plan for surveillance management. However, the mass continued to enlarge and the lesion was therefore biopsied when the infant was 17 months old. Histology showed plump epithelioid tumor cells, in many places lining pseudoalveolar spaces. Occasional Pas-D inclusions were present in the cytoplasm. Immunostaining showed nuclear positivity for TFE-3. Real-time quantitative polymerase chain reaction testing confirmed the presence of ASPSCR1-TFE3 fusion transcripts, characteristic of the translocation t(X;17) p(11.2;q25) observed in ASPS. This represents the youngest reported ASPS case with a confirmed molecular diagnosis. Complete surgical resection was undertaken and a surveillance imaging schedule implemented. This case highlights the need for regular review of the initial diagnosis and the importance of multidisciplinary discussion and early biopsy where the clinical course does not follow that expected for the putative (nonhistologically confirmed) diagnosis.
Introduction
Alveolar soft part sarcoma (ASPS) is an exceptionally rare tumor, compromising just a small proportion of all sarcomas. One recent article described 22 (translocationpositive) cases arising at various anatomical sites across 10-year enrollment on the multinational European Paediatric Soft-Tissue-Sarcoma Study Group (EpSSG) non-rhabdomyosarcomatous soft tissue sarcoma (NRSTS) 2005 study, 1 and another described 69 pediatric and young adult cases across a 34-year timeframe from the United States. 2 Median age at diagnosis in the studies was 11.5 and 17 years, with a range from 2.7 to 17.5 and 1.5 to 30 years, respectively.
1,2 Six of 22 cases (27%) were at head and neck sites, and 6 of 69 (9%) specifically at oral (pharynx/lingual) sites in the European and U.S. studies, respectively. 1, 2 These data are consistent with lingual ASPS compromising only a small proportion of all ASPS cases. 3 Here, with full informed parental 1 consent, we report the youngest described case of confirmed translocation-positive lingual ASPS.
Case Report
An erythematous swelling was noted on the right aspect of the tongue when the infant was 11 months old. This was initially monitored in primary care before subsequent referral to general pediatrics, with subsequent onward referral to the maxillofacial team. A magnetic resonance imaging (MRI) scan demonstrated a focal 16 mm lesion within the right side of the anterior tongue ( Figure 1(A) ) with some moderately enhancing vessels. Given the clinical and radiologic features were consistent with an infantile hemangioma, interval maxillofacial follow-up was arranged. During follow-up, the lesion gradually increased in size, with the infant also experiencing drooling, difficulty with eating, and contact bleeding of the lesion. She therefore underwent biopsy at 17 months of age, 6 months following initial presentation, confirming ASPS. Following biopsy, the lesion underwent a rapid growth phase. Urgent imaging was performed to plan definitive surgery and for staging purposes; this confirmed localized disease with a now predominantly exophytic and intensely enhancing 37 Â 35 Â 32 mm lingual lesion ( Figure 1(B) ). Due to acute airway concerns from the lesion at this time ( the expression of INI-1 was retained. Desmin, pancytokeratin, CD56, and CD99 were negative. CD34 staining highlighted a prominent vascular network within the tumor. On the initial biopsy, the surface of the tongue showed ulceration and granulation tissue formation. RQ-PCR testing confirmed the presence of ASPSCR1-TFE3 fusion transcripts, characteristic of the translocation t(X;17) p(11.2;q25) seen in ASPS. The tumor had pushing margins and despite macroscopic excision at surgery, disease was present within 0.1 mm of the deep margin, at which definite vascular invasion was also present. Consequently, following discussion with the UK Pediatric National Sarcoma Advisory Panel, the infant underwent further local excision. Pathology of this specimen confirmed clear margins, with only scar tissue present, and no residual disease seen. Following surgery, the infant had excellent functional recovery, with rapid removal of the tracheostomy. A close follow-up surveillance program was instigated, with regular clinical review and initial 3 monthly MRI head and neck imaging of the primary tumor site. Chest X-ray imaging was also performed monthly 3 times in initial follow-up to assess for the infrequent occurrence of pulmonary metastasis. At 14 months following primary resection, the child remained in clinical and radiologic remission. Functional progress was excellent, with the child having intact swallow and dramatically improved speech.
Discussion
This case, describing a young infant with lingual ASPS, has a number of features which make it important to report. First, our patient is the youngest reported patient with ASPS with the characteristic ASPSCR1-TFE3 fusion. Second, this tumor occurred at an unusual site, with lingual lesions compromising only a small proportion of all ASPS.
The diagnosis of sarcoma can be challenging, particularly in young children, where malignancy is extremely rare and benign soft tissue lesions are common. Sarcomas can mimic these common benign lesions not only clinically but also radiologically, as described in this case. Sarcomas can masquerade as infantile hemangiomas, 4 which is a particular challenge given the incidence of the latter, which are observed in approximately 4% to 5% of all infants. 5 Similar diagnostic challenges to our case were described in a 6-month-old male infant with a small nodule in the inner canthus of the right eye. 4 This was also initially diagnosed as an infantile hemangioma, but later biopsy confirmed alveolar rhabdomyosarcoma. Indeed, many malignant diagnoses have been reported as being able to masquerade as infantile hemangiomas, including but not limited to congenital leukemia cutis, 6 metastatic neuroblastoma, 7 congenital self-healing reticulo-histiocytosis, 6 and metastatic choriocarcinoma. 8 For lesions within the oral cavity, studies report benign pathology in 84% to 99% of cases, 9 which mainly arise from the mesenchyme. A pyogenic granuloma (lobular capillary hemangioma) is a vascular lesion which can grow rapidly and bleed on palpation, and which may therefore have presented similarly to our case. An 'irritation' fibroma, or focal fibrous hyperplasia of the oral mucosa, is the most common benign tumor of the oral cavity and although more commonly seen in adults, can occur at any age, including cases described relating to natal teeth 10 or thumb sucking. 11 Another benign tumor, albeit present from birth, is congenital epulis or granular cell tumor; these arise most commonly from the alveolar ridges of the maxilla and mandible. The lesions can vary from a few millimetres in diameter to large tumors obstructing the airway or interfering with feeding, which are treated with surgery. 12 Other rare differentials include rhabdomyosarcoma, fibrosarcoma, paraganglioma, and neuroblastoma metastasis.
These diagnostic challenges highlight the importance of multidisciplinary discussion and early biopsy where the clinical course does not follow that expected for the putative (nonhistologically confirmed) diagnosis. This will ensure prompt and timely management is instigated which will optimize patient outcomes.
In the reported series of 69 pediatric and young adult ASPS cases ranging from 1.5 to 30 years, 26 were confirmed to be ASPSCR1-TFE3 translocation-positive, 2 and it is not clear which specific cases harbored this molecular abnormality. Consequently, the presence of the characteristic ASPSCR1-TFE3 fusion in the 17-month-old infant described here represents, to our knowledge, the youngest reported ASPS case with a confirmed molecular diagnosis.
Our infant has had an excellent outcome during early surveillance following surgery alone, consistent with the treatment outcomes described in the literature. The majority of children with ASPS have localized disease, including 20 of 22 cases in the purely pediatric ASPS series.
1 Surgery was the mainstay of therapy for ASPS, and there were no responses to conventional chemotherapy. 1 Furthermore, the role of radiotherapy for ASPS has still to be elucidated. In contrast to series including adult ASPS cases, 2 outcomes in this pediatric cohort were excellent, with reported event-free and overall survival rates of 94.7% and 100%, respectively.
1 These outcomes are entirely consistent with those reported in 14 purely lingual ASPS cases, 3 where patients were aged 3 to 21 years (median 5 years) at diagnosis. Importantly, 10 of the patients with follow-up data available were all alive without disease, despite vascular invasion being a typical feature of lingual cases, as described here. 3 The authors suggest that the better prognosis in lingual tumors compared with adult ASPS may be due to early diagnosis and smaller tumor size at presentation. 3 However, late ASPS recurrence may still occur as median follow-up in the published series is still relatively short at 61.7 1 and 46 months, 2 respectively, particularly given the indolent nature of the disease described in adults. 13 Therefore, some caution needs to be taken in the excellent outcomes reported, as in cases of unresectable or widely metastatic ASPS disease, there is no known curative treatment. Patients who subsequently present with a single metastatic pulmonary lesion have, however, been cured by complete surgical resection. 3 Targeted treatments are now also being trialed in ASPS with some promising results. 2 Further studies are required, although the true efficacy of novel agents will be difficult to assess given both the rarity of the disease and the observation that the disease may remain stable for lengthy periods.
